Gyre Therapeutics, Inc. Shares Outstanding (Cover Page)
Gyre Therapeutics, Inc. (GYRE) had Shares Outstanding (Cover Page) of 111.51 million shares as of 2026-08-01, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-07
- 2026-08-01: Entity Common Stock, Shares Outstanding 111.51M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 97.03M shares.
- 2026-03-02: Entity Common Stock, Shares Outstanding 96.96M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 96.33M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-01 | 111.51M shares 10-Q · filed 2026-08-07 |
| 2026-05-01 | 97.03M shares 10-Q · filed 2026-05-08 |
| 2026-03-02 | 96.96M shares 10-K · filed 2026-03-13 |
| 2025-10-31 | 96.33M shares 10-Q · filed 2025-11-07 |
| 2025-07-31 | 96.31M shares 10-Q · filed 2025-08-11 |
| 2025-05-01 | 93.76M shares 10-Q · filed 2025-05-09 |
| 2025-03-07 | 93.61M shares 10-K · filed 2025-03-17 |
| 2024-11-08 | 93.52M shares 10-Q · filed 2024-11-13 |
| 2024-08-06 | 93.42M shares 10-Q · filed 2024-08-13 |
| 2024-05-06 | 85.51M shares 10-Q · filed 2024-05-13 |
| 2024-03-19 | 85.42M shares 10-K · filed 2024-03-27 |
| 2023-10-20 | 37.98M shares 10-Q · filed 2023-10-26 |
| 2023-08-04 | 37.97M shares 10-Q · filed 2023-08-14 |
| 2023-05-08 | 37.76M shares 10-Q · filed 2023-05-15 |
| 2023-03-24 | 37.76M shares 10-K · filed 2023-03-30 |
| 2022-11-07 | 31.49M shares 10-Q · filed 2022-11-14 |
| 2022-07-29 | 31.48M shares 10-Q · filed 2022-08-15 |
| 2022-04-29 | 31.48M shares 10-Q · filed 2022-05-09 |
| 2022-03-31 | 31.48M shares 10-K/A · filed 2022-05-02 |
| 2022-03-25 | 31.48M shares 10-K · filed 2022-03-31 |
| 2021-11-08 | 31.41M shares 10-Q · filed 2021-11-12 |
| 2021-07-30 | 31.37M shares 10-Q · filed 2021-08-05 |
| 2021-04-29 | 31.35M shares 10-Q · filed 2021-05-06 |
| 2021-02-25 | 31.33M shares 10-K · filed 2021-03-04 |
| 2020-10-29 | 22.10M shares 10-Q · filed 2020-11-05 |
| 2020-07-30 | 22.06M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 17.44M shares 10-Q · filed 2020-05-11 |
| 2020-02-07 | 12.08M shares 10-K · filed 2020-02-20 |
| 2019-10-25 | 12.04M shares 10-Q · filed 2019-11-07 |
| 2019-07-26 | 12.02M shares 10-Q · filed 2019-08-01 |
| 2019-04-30 | 11.98M shares 10-Q · filed 2019-05-02 |
| 2019-03-04 | 11.97M shares 10-K · filed 2019-03-08 |
| 2018-10-29 | 11.94M shares 10-Q · filed 2018-11-01 |
| 2018-07-31 | 11.94M shares 10-Q · filed 2018-08-02 |
| 2018-04-30 | 11.94M shares 10-Q · filed 2018-05-03 |
| 2018-03-15 | 11.89M shares 10-K · filed 2018-03-19 |
| 2017-10-31 | 4.31M shares 10-Q · filed 2017-11-02 |
| 2017-07-31 | 4.31M shares 10-Q · filed 2017-08-03 |
| 2017-05-04 | 4.26M shares 10-Q · filed 2017-05-11 |
| 2017-02-28 | 1.00M shares 10-K · filed 2017-03-08 |
| 2016-10-31 | 12.03M shares 10-Q · filed 2016-11-03 |
| 2016-07-29 | 11.84M shares 10-Q · filed 2016-08-04 |
| 2016-04-29 | 11.43M shares 10-Q · filed 2016-05-05 |
| 2016-03-01 | 11.43M shares 10-K · filed 2016-03-09 |
| 2015-10-30 | 11.43M shares 10-Q · filed 2015-11-05 |
| 2015-07-27 | 34.29M shares 10-Q · filed 2015-07-31 |
| 2015-04-30 | 33.87M shares 10-Q · filed 2015-05-07 |
| 2015-02-28 | 33.79M shares 10-K · filed 2015-03-16 |
| 2014-10-31 | 34.31M shares 10-Q · filed 2014-11-06 |
| 2014-07-31 | 33.79M shares 10-Q · filed 2014-08-07 |
| 2014-04-30 | 33.78M shares 10-Q · filed 2014-05-08 |
| 2014-02-28 | 33.74M shares 10-K · filed 2014-03-14 |
| 2013-10-31 | 33.66M shares 10-Q · filed 2013-11-06 |
| 2013-07-31 | 33.64M shares 10-Q · filed 2013-08-07 |
| 2013-04-30 | 33.62M shares 10-Q · filed 2013-05-08 |
| 2013-02-28 | 33.62M shares 10-K · filed 2013-03-15 |
| 2012-10-31 | 33.61M shares 10-Q · filed 2012-11-08 |
| 2012-07-31 | 33.43M shares 10-Q · filed 2012-08-09 |
| 2012-04-30 | 33.40M shares 10-Q · filed 2012-05-09 |
| 2012-02-29 | 33.40M shares 10-K · filed 2012-03-06 |
| 2011-10-31 | 33.38M shares 10-Q · filed 2011-11-03 |
| 2011-07-31 | 33.38M shares 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |